Search PDMR transactions

Notifier
Name
Andreas Gerward
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Andreas Gerward
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
Stayble Therapeutics AB
LEI of Issuer
549300WD23DE1US21868
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA STABL BTA SE0015504139 Subscription 15,000 Quantity 6.00 SEK 16/02/2021 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
STABL BTA SE0015504139 Subscription 16/02/2021 Outside a trading venue 15,000 (Quantity) 6.00 SEK
Total: 15,000
<< Back